Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
RELATED: Biotech Exec Warns That Weight-Loss Drugs Do "More Harm Than Good." Due to their injectable delivery, these ...
Rapper Fat Joe recently shared how he’s been using the Type 2 diabetes medication Ozempic to maintain his 200-pound weight ...
Fat Joe opened up about his weight loss journey, and explained that he's been focusing on a new diet alongside semaglutide ...